AN2 Therapeutics, Inc. (ANTX) KPIs and segments

ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$4.55+0.11 (+2.48%)

Close on Nov 13, 2026Market cap $171.70MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive AN2 Therapeutics's business

Coming soon

This tab will track the numbers specific to AN2 Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?